Can CVS Health Maintain Its Growth Through the End of 2025?

CVS Health is undergoing a significant turnaround, with its shares up 77% this year, driven by improved financial performance and strategic adjustments. The company reported record third-quarter revenue of $102.9 billion (+7.8% YoY) and strong adjusted operating income of $3.5 billion (+35.8% YoY) and non-GAAP EPS of $1.60 (+47% YoY), despite a non-cash goodwill impairment. CVS is addressing past profitability challenges by implementing a $2 billion cost-saving plan, scaling back its Medicare Advantage business, and exiting the Affordable Care Act market. These actions, combined with an attractive valuation of 10.7x forward earnings and a 3.4% dividend yield, position the company for continued momentum and long-term growth through its integrated health ecosystem.

Analysis

CVS Health has demonstrated a significant financial turnaround, with its shares appreciating 77% this year, driven by robust third-quarter results. The company reported record revenue of $102.9 billion, a 7.8% year-over-year increase, alongside a 35.8% rise in adjusted operating income to $3.5 billion and a 47% surge in non-GAAP earnings per share to $1.60, despite a $5.7 billion non-cash goodwill impairment. These adjusted metrics provide a clearer indication of underlying business health and momentum.

The company is actively addressing past profitability challenges through strategic portfolio adjustments and cost-saving measures. CVS initiated a plan to achieve at least $2 billion in cost savings over several years and is scaling back its Medicare Advantage business while exiting the Affordable Care Act's health insurance market. These actions, though potentially leading to lower overall revenue, are expected to drive stronger near-to-medium term top- and bottom-line growth.

CVS Health's current valuation appears attractive, trading at 10.7 times forward earnings compared to the healthcare industry average of 17.1. This, combined with a forward dividend yield of 3.4% and a 53.3% cash payout ratio, positions it as a compelling option for both growth and income. The company's extensive network and integrated health ecosystem are expected to benefit from long-term tailwinds such as an aging population, supporting sustained performance.

Key Decisions for Investors

• Monitor the execution and impact of CVS Health's $2 billion cost-saving initiatives and strategic exits from less profitable segments like Medicare Advantage and ACA.
• Evaluate the sustainability of margin expansion and adjusted earnings growth as these strategic shifts mature, especially given the attractive valuation relative to peers.
• Consider CVS Health for long-term, income-oriented portfolios due to its robust dividend yield and exposure to favorable demographic trends in healthcare.